377 related articles for article (PubMed ID: 10630188)
41. Effects of overexpression of the cytoplasmic copper-zinc superoxide dismutase on the survival of neurons in vitro.
Schwartz PJ; Coyle JT
Synapse; 1998 Jul; 29(3):206-12. PubMed ID: 9635890
[TBL] [Abstract][Full Text] [Related]
42. Cu/Zn SOD deficiency potentiates hearing loss and cochlear pathology in aged 129,CD-1 mice.
McFadden SL; Ding D; Burkard RF; Jiang H; Reaume AG; Flood DG; Salvi RJ
J Comp Neurol; 1999 Oct; 413(1):101-12. PubMed ID: 10464373
[TBL] [Abstract][Full Text] [Related]
43. Expressions of nitrotyrosine and TUNEL immunoreactivities in cultured rat spinal cord neurons after exposure to glutamate, nitric oxide, or peroxynitrite.
Manabe Y; Wang JM; Murakami T; Warita H; Hayashi T; Shoji M; Abe K
J Neurosci Res; 2001 Sep; 65(5):371-7. PubMed ID: 11536319
[TBL] [Abstract][Full Text] [Related]
44. [Molecular mechanism of ALS and a possible gene therapy].
Abe K; Warita H
Rinsho Shinkeigaku; 1999 Jan; 39(1):68-9. PubMed ID: 10377808
[TBL] [Abstract][Full Text] [Related]
45. Alteration in intracellular calcium homeostasis reduces motor neuronal viability expressing mutated Cu/Zn superoxide dismutase through a nitric oxide/guanylyl cyclase cGMP cascade.
Kim HJ; Kim M; Kim SH; Sung JJ; Lee KW
Neuroreport; 2002 Jul; 13(9):1131-5. PubMed ID: 12151755
[TBL] [Abstract][Full Text] [Related]
46. Sera from amyotrophic lateral sclerosis patients induce the non-canonical activation of NMDA receptors "in vitro".
Texidó L; Hernández S; Martín-Satué M; Povedano M; Casanovas A; Esquerda J; Marsal J; Solsona C
Neurochem Int; 2011 Nov; 59(6):954-64. PubMed ID: 21782871
[TBL] [Abstract][Full Text] [Related]
47. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice.
Damiano M; Starkov AA; Petri S; Kipiani K; Kiaei M; Mattiazzi M; Flint Beal M; Manfredi G
J Neurochem; 2006 Mar; 96(5):1349-61. PubMed ID: 16478527
[TBL] [Abstract][Full Text] [Related]
48. Mitochondrial Dysfunction during the Early Stages of Excitotoxic Spinal Motor Neuron Degeneration in Vivo.
Santa-Cruz LD; Guerrero-Castillo S; Uribe-Carvajal S; Tapia R
ACS Chem Neurosci; 2016 Jul; 7(7):886-96. PubMed ID: 27090876
[TBL] [Abstract][Full Text] [Related]
49. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease.
Tikka TM; Vartiainen NE; Goldsteins G; Oja SS; Andersen PM; Marklund SL; Koistinaho J
Brain; 2002 Apr; 125(Pt 4):722-31. PubMed ID: 11912107
[TBL] [Abstract][Full Text] [Related]
50. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.
Gurney ME; Pu H; Chiu AY; Dal Canto MC; Polchow CY; Alexander DD; Caliendo J; Hentati A; Kwon YW; Deng HX
Science; 1994 Jun; 264(5166):1772-5. PubMed ID: 8209258
[TBL] [Abstract][Full Text] [Related]
51. Marked synergism between mutant SOD1 and glutamate transport inhibition in the induction of motor neuronal degeneration in spinal cord slice cultures.
Yin HZ; Weiss JH
Brain Res; 2012 Apr; 1448():153-62. PubMed ID: 22370146
[TBL] [Abstract][Full Text] [Related]
52. Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice.
Jaiswal MK; Keller BU
Mol Pharmacol; 2009 Mar; 75(3):478-89. PubMed ID: 19060114
[TBL] [Abstract][Full Text] [Related]
53. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice.
Guo Q; Fu W; Sopher BL; Miller MW; Ware CB; Martin GM; Mattson MP
Nat Med; 1999 Jan; 5(1):101-6. PubMed ID: 9883847
[TBL] [Abstract][Full Text] [Related]
54. Excitotoxicity and amyotrophic lateral sclerosis.
Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
[TBL] [Abstract][Full Text] [Related]
55. Respiration and ROS production in brain and spinal cord mitochondria of transgenic rats with mutant G93a Cu/Zn-superoxide dismutase gene.
Panov A; Kubalik N; Zinchenko N; Hemendinger R; Dikalov S; Bonkovsky HL
Neurobiol Dis; 2011 Oct; 44(1):53-62. PubMed ID: 21745570
[TBL] [Abstract][Full Text] [Related]
56. Exposure to an environmental neurotoxicant hastens the onset of amyotrophic lateral sclerosis-like phenotype in human Cu2+/Zn2+ superoxide dismutase 1 G93A mice: glutamate-mediated excitotoxicity.
Johnson FO; Yuan Y; Hajela RK; Chitrakar A; Parsell DM; Atchison WD
J Pharmacol Exp Ther; 2011 Aug; 338(2):518-27. PubMed ID: 21586603
[TBL] [Abstract][Full Text] [Related]
57. Superoxide dismutase deficiency enhances superoxide levels in brain tissues during oxygenation and hypoxia-reoxygenation.
Sasaki T; Shimizu T; Koyama T; Sakai M; Uchiyama S; Kawakami S; Noda Y; Shirasawa T; Kojima S
J Neurosci Res; 2011 Apr; 89(4):601-10. PubMed ID: 21280062
[TBL] [Abstract][Full Text] [Related]
58. Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons.
Bar-Peled O; Korkotian E; Segal M; Groner Y
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8530-5. PubMed ID: 8710904
[TBL] [Abstract][Full Text] [Related]
59. Riluzole and ALS therapy.
Hugon J
Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
[TBL] [Abstract][Full Text] [Related]
60. Decrease in Cu/Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis.
Uchino M; Ando Y; Tanaka Y; Nakamura T; Uyama E; Mita S; Murakami T; Ando M
J Neurol Sci; 1994 Dec; 127(1):61-7. PubMed ID: 7699393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
